Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST Study
ClinicoEconomics and Outcomes Research · 2026-03 · Volume 18 · 1-9
DOI: 10.2147/ceor.s581258 ↗Kurz gefasst
Fachartikel in der Zeitschrift ClinicoEconomics and Outcomes Research, 2026-03. Verfasst von Satoshi Yoshihara und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Hyogo Medical University, Nishinomiya, Japan. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Hyogo Medical University, Nishinomiya, Japan.
- Real World Evidence - Oncology, Pfizer Inc, New York, NY, USA.
- Patient and Health Impact, Pfizer Inc, New York, NY, USA.
- Statlog Inc, Quebec, QC, Canada.
- Oncology Medical - Global Hematology, Pfizer Ltd, Surrey, UK.
- Oncology Medical Affairs, Pfizer Japan Inc, Tokyo, Japan.
ORCID-Profile: Satoshi Yoshihara, Marco DiBonaventura
Zitieren
APA
Yoshihara, S., Meche, A., Hlavacek, P., Johnson, S. M. A., Demers, A. S., Nador, G., Ikoma, S., Yadav, C. P., Assaf, C. A. L., DiBonaventura, M., & Chen, Y. (2026). Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST Study. ClinicoEconomics and Outcomes Research, Volume 18, 1-9. https://doi.org/10.2147/ceor.s581258
Vancouver
Yoshihara S, Meche A, Hlavacek P, Johnson SMA, Demers AS, Nador G, et al. Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST Study. ClinicoEconomics and Outcomes Research. 2026;Volume 18:1-9. doi:10.2147/ceor.s581258
BibTeX
@article{Yoshihara2026,
author = {Yoshihara, Satoshi and Meche, Aster and Hlavacek, Patrick and Johnson, Sarasa M A and Demers, Ann-Sophie and Nador, Guido and Ikoma, Shohei and Yadav, Chandra Prakash and Assaf, Carla A L and DiBonaventura, Marco and Chen, Yong},
title = {Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST Study},
journal = {ClinicoEconomics and Outcomes Research},
year = {2026},
volume = {Volume 18},
pages = {1--9},
doi = {10.2147/ceor.s581258}
}
EUVIMED